Novavax Inc (NVAX)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$7.19

Buy

$7.21

arrow-down$-0.545 (-7.02%)

Prices updated at 14 Nov 2024, 21:56 EST

Prices minimum 15 mins delay

Prices in USD

Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.

NASDAQ

-0.64%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

Key dates

	Forecast date
Half yearly results	Aug 2025
Annual general meeting	Jun 2025
Annual report	Feb 2025
Final results	Feb 2025

	Previous date
Half yearly results	Aug 2024
Annual general meeting	Jun 2024
Annual report	Feb 2024
Final results	Feb 2024

Company reports

31 Dec 2023

Annual Report

30 Sep 2023

Quarterly Report

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.